Erschienen in:
01.07.2014 | Breast Oncology
Internal Mammary Sentinel Lymph Node Biopsy: Minimally Invasive Staging and Tailored Internal Mammary Radiotherapy
verfasst von:
Bin-Bin Cong, MA, Peng-Fei Qiu, MA, Yong-Sheng Wang, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 7/2014
Einloggen, um Zugang zu erhalten
Excerpt
Internal mammary lymph node (IMLN) metastasis has a similar prognostic importance as axillary lymph nodal involvement in breast cancer patients. Even though TNM staging has incorporated the internal mammary sentinel lymph node biopsy (IM-SLNB) concept since the 6th edition of the American Joint Committee on Cancer, IM-SLNB has not been performed routinely and has remained a subject of discussion. In fact, accurate staging could not be achieved by depending on the status of the axillary sentinel lymph node alone, which might lead to under-stage and under-treatment. The recent studies of Caudle et al.
1 and Gnerlich et al.
2 showed again that IM-SLNB was a minimally invasive technique for the efficient evaluation of the status of internal mammary sentinel lymph nodes (IM-SLN) with high safety and feasibility. Gnerlich et al.
2 reported no complications in their study, and Caudle et al.
1 found only two intraoperative surgical complications, but both were resolved smoothly. In our current study, there is no pneumothorax on postoperative chest radiography and no postoperative bleeding. IM-SLNB had made a more accurate lymph node staging and improved the decision making of the adjuvant radiotherapy of the IMLN, and even adjuvant systemic therapy in some cases. …
